Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Big Win For VVUS

|Includes: Vivus, Inc. (VVUS)

The FDA advisory panel this afternoon voted in favour of VVUS' obesity drug QNEXA by a margin of 20-2. Last year the panel voted against the drug bu 10-6. VVUS has a PDUFA date in April.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.